MENU
  • About Us
    • Profile
  • Blog
    • Comment Policy
  • Series
    • Bispecific Antibody
    • ADC
    • CAR-T
    • KRAS Deep Dive
    • Oncology Approvals
  • Category
  • Contact Us
  • 日本語
  • English
Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~
  • About Us
    • Profile
  • Blog
    • Comment Policy
  • Series
    • Bispecific Antibody
    • ADC
    • CAR-T
    • KRAS Deep Dive
    • Oncology Approvals
  • Category
  • Contact Us
  • 日本語
  • English
  • About Us
  • Blog
  • Series
  • Category
  • Contact Us
  • 日本語
  • English
Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~
  • About Us
    • Profile
  • Blog
    • Comment Policy
  • Series
    • Bispecific Antibody
    • ADC
    • CAR-T
    • KRAS Deep Dive
    • Oncology Approvals
  • Category
  • Contact Us
  • 日本語
  • English
  1. Home
  2. anti-obesity drug

anti-obesity drug– tag –

  • Beginner-friendly

    Summer Beginner Series Grand Summary Part 2|The Rise of Bispecific Antibodies and the Future of Next-Generation Modalities

    This article is the second half of the Morningglorysciences Summer Beginner Series Grand Summary. This article is the second half of the Morningglorysciences Summer Beginner Series Grand Summary. In Part 1, we reviewed anti-obesity drugs...
    2025-08-23
  • Beginner-friendly

    Summer Special Beginner Series Summary|Anti-Obesity Drugs: From GLP-1 to Next-Generation Therapies

    This article is a comprehensive summary of our Morningglorysciences Summer Beginner Series on anti-obesity drugs. This article is a comprehensive summary of our Morningglorysciences Summer Beginner Series on anti-obesity drugs. Throughou...
    2025-08-17
1
MorningMorning|管理人

創薬の最前線に20年以上。基礎研究から新薬開発、そして投資の側まで――投資家の視点も持ちながら、がん領域を軸に日米欧で歩いてきました。最先端のがん治療・創薬・AI創薬・バイオ投資を、正確に、面白く、毎日お届けします。

▶ もっと詳しく(プロフィール)

▶ X:@MorningGlorySci

コメント・ご質問、お待ちしています。

MorningMorning|Author

20+ years at the frontline of drug discovery — from basic research to development to the investor's side. Oncology-focused, across Japan, the US, and Europe. Cutting-edge cancer therapy, drug discovery, AI drug development, and biotech investment — accurate and engaging, every day.

▶ More (Profile)

▶ X: @MorningGlorySci

Comments & questions welcome.

  • Disclaimer
  • Privacy Policy
  • Sitemap
  • Contact Us
  • 日本語

© Create the Most Advanced Therapeutics ~ Pharmas, Biotech Ventures, and Investors~.

  • Menu
  • Disclaimer
  • Privacy Policy
  • Sitemap
  • Contact Us
  • 日本語